BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cruz-Torres I, Backos DS, Herson PS. Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX. Mol Pharmacol 2020;97:102-11. [PMID: 31772034 DOI: 10.1124/mol.119.117549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Liu J, Yu B, Jin Y, Li J, Ma X, Yu J, Niu J, Liang X. Umbilical cord-derived mesenchymal stem cell conditioned medium reverses neuronal oxidative injury by inhibition of TRPM2 activation and the JNK signaling pathway. Mol Biol Rep 2022. [PMID: 35585377 DOI: 10.1007/s11033-022-07524-9] [Reference Citation Analysis]
2 Bracke F, Frieling H, Leffler A. Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2. Pharmacology 2022;:1-8. [PMID: 35584608 DOI: 10.1159/000524934] [Reference Citation Analysis]
3 Vaidya B, Kaur H, Thapak P, Sharma SS, Singh JN. Pharmacological Modulation of TRPM2 Channels via PARP Pathway Leads to Neuroprotection in MPTP-induced Parkinson's Disease in Sprague Dawley Rats. Mol Neurobiol 2022. [PMID: 34997907 DOI: 10.1007/s12035-021-02711-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Dietz RM, Orfila JE, Chalmers N, Minjarez C, Vigil J, Deng G, Quillinan N, Herson PS. Functional Restoration following Global Cerebral Ischemia in Juvenile Mice following Inhibition of Transient Receptor Potential M2 (TRPM2) Ion Channels. Neural Plast 2021;2021:8774663. [PMID: 34659399 DOI: 10.1155/2021/8774663] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Alemán OR, Mora N, Rosales C. The Antibody Receptor Fc Gamma Receptor IIIb Induces Calcium Entry via Transient Receptor Potential Melastatin 2 in Human Neutrophils. Front Immunol 2021;12:657393. [PMID: 34054821 DOI: 10.3389/fimmu.2021.657393] [Reference Citation Analysis]
6 Zhang H, Yu P, Lin H, Jin Z, Zhao S, Zhang Y, Xu Q, Jin H, Liu Z, Yang W, Zhang L. The Discovery of Novel ACA Derivatives as Specific TRPM2 Inhibitors that Reduce Ischemic Injury Both In Vitro and In Vivo. J Med Chem 2021;64:3976-96. [PMID: 33784097 DOI: 10.1021/acs.jmedchem.0c02129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Zhang H, Zhao S, Yu J, Yang W, Liu Z, Zhang L. Medicinal chemistry perspective of TRPM2 channel inhibitors: where we are and where we might be heading? Drug Discov Today 2020;25:2326-34. [PMID: 33065292 DOI: 10.1016/j.drudis.2020.09.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]